APA (7th ed.) Citation

KJS, B., JD, P., TM, A., C, P., M, P., JW, S., & J, R. (2023). International Society for Quality of Life Research commentary on the US Food and Drug Administration draft guidance for industry on core patient-reported outcomes in cancer clinical trials. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 32(8), 2155. https://doi.org/10.1007/s11136-023-03396-z

Chicago Style (17th ed.) Citation

KJS, Brady, Peipert JD, Atkinson TM, Pompili C, Pinto M, Shaw JW, and Roydhouse J. "International Society for Quality of Life Research Commentary on the US Food and Drug Administration Draft Guidance for Industry on Core Patient-reported Outcomes in Cancer Clinical Trials." Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation 32, no. 8 (2023): 2155. https://doi.org/10.1007/s11136-023-03396-z.

MLA (9th ed.) Citation

KJS, Brady, et al. "International Society for Quality of Life Research Commentary on the US Food and Drug Administration Draft Guidance for Industry on Core Patient-reported Outcomes in Cancer Clinical Trials." Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, vol. 32, no. 8, 2023, p. 2155, https://doi.org/10.1007/s11136-023-03396-z.